| 产品详情 |
| Edit |   |
|---|
| Product Name | GSK2636771 |
|---|
| Description | An orally bioavailable inhibitor of PI3K p110β that decreases cell viability and Akt phosphorylation in p100β-dependent PTEN-deficient PC-3 prostate and BT549 and HCC70 breast cancer cell lines |
|---|
| Size | 500 µg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 1372540-91-4 GSK 2636771 PI3Kβ PI3K-β phosphoinositide 3-kinase phosphatidylinositol PTEN-deficient tumor PI3K p110β p110B PI3K-B PI3KB GSK2636771B 2636771B p110-B p110-β PI3-K PI3-KB PI3-Kβ |
|---|
| Gene, Accession, CAS # | CAS: 1372540-25-4 |
|---|
| Catalog # | 17380-500 |
|---|
| Price | |
|---|
| Order / More Info | GSK2636771 from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|